drugset / Trial / NCT00232674

Efficacy Study of the Effect of Budesonide on Emphysema

NCT00232674

Phase 4 Completed 240 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the effect of up to 4 years treatment with budesonide on progression of emphysema in patients with Chronic Obstructive Lung Disease.

Timeline

Start
1999-07
Primary completion
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule Inhaled